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Hermansky–Pudlak syndrome (HPS) is an autosomal recessive disorder characterized by oculocutaneous albinism
(OCA), bleeding tendency, and lysosomal accumulation of ceroid-like material. Seven genetically distinct subtypes
of HPS are known in humans; most are rare outside of Puerto Rico. Here, we describe the analysis of the HPS1 gene
in 24 Japanese OCA patients who lacked mutations in the four genes known to cause OCA (TYR/OCA1, P/OCA2,
TYRP1/OCA3, and MATP/OCA4), and the identiﬁcation of eight different HPS1 mutations in ten of these patients,
four of which were novel (W583X, L668P, 532insC, 1691delA). An IVS5þ 5G ! A splice consensus mutation was
particularly frequent, the result of a founder effect for this allele in Japanese patients. Functional analysis by
transfection of the L668P variant into Hps1-mutant melan-ep mouse melanocytes showed that this missense sub-
stitution is pathologic, resulting in an Hps-1 protein that is unable to assemble into the biogenesis of lysosome-
related organelles complex-3.
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Hermansky–Pudlak syndrome (HPS; MIM# 203300) is an
autosomal recessive disorder characterized by oculocuta-
neous albinism (OCA), bleeding tendency because of a lack
of platelet-dense granules, and lysosomal accumulation of
ceroid-like material (Spritz, 1999; Huizing et al, 2000; Star-
cevic et al, 2002). Life-threatening manifestations are fre-
quent, and death typically results from restrictive lung
disease in patients aged 30–50 y, or in some cases from
granulomatous colitis, although the clinical course can be
quite variable (Gahl et al, 1998).
Seven genetically distinct subtypes of HPS have been
defined in humans, resulting from mutations in seven dif-
ferent genes: HPS1, ADTB3A, HPS3, HPS4, HPS5, HPS6,
and DTNBP1 (Oh et al, 1996; Dell’Angelica et al, 1999; An-
ikster et al, 2001; Suzuki et al, 2002; Li et al, 2003; Zhang
et al, 2003). HPS type 1 (HPS1) is the most common, ac-
counting for perhaps half of all cases (Oh et al, 1998). Al-
though rare in most populations, HPS1 occurs with a
frequency of  1 per 1800 on the island of Puerto Rico
(Witkop et al, 1990), where essentially all HPS1 patients are
homozygous for a 16 bp frameshift duplication at codons
491–496 (Oh et al, 1996), a result of a founder effect and
occult inbreeding (Fukai et al, 1995). Among Japanese pa-
tients, four different HPS1 gene mutations (IVS5þ5G ! A,
962insG, 441insA, and 332delC) have been reported (Oh
et al, 1996, 1998; Horikawa et al, 2000). Altogether, more
than 18 different pathological mutations of the HPS1 gene
have been described (Gahl et al, 1998; Oh et al, 1998; Her-
mos et al, 2002; reviewed in Oetting and King, 1999).
The specific function of the HPS1 protein remains un-
known. It is associated with the product of the HPS4 locus
in a protein complex named biogenesis of lysosome-related
organelles complex (BLOC)-3 (Oh et al, 2000; Chiang et al,
2003; Nazarian et al, 2003). Absent expression of the HPS4
protein destabilizes BLOC-3, resulting in loss of HPS1 as
well (Chiang et al, 2003).
We previously showed that, of 93 unrelated Japanese
patients with OCA, 24 lacked apparent mutations in the four
known OCA genes (TYR/OCA1, P/OCA2, TYRP1/OCA3,
and MATP/OCA4) (Tomita et al, 2000; Suzuki et al, 2003;
Inagaki et al, 2004). Here, we describe analysis of the HPS1
gene in these 24 patients and the identification of eight dif-
ferent HPS1 mutations, four of which were novel (W583X,
L668P, 532insC, 1691delA). An IVS5þ 5G ! A splice con-1The first two authors contributed equally to this work.
Abbreviations: BLOC, biogenesis of lysosome-related organelles
complex; HPS, Hermansky-Pudlak syndrome; HRP, horseradish
peroxidase; OCA, oculocutaneous albinism; SNP, single nucleotide
polymorphism; SSCP, single-strand conformation polymorphism
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sensus mutation was particularly frequent, a result of a
founder effect for this allele in Japanese patients. Functional
analysis of the L668P variant showed that this missense
substitution is pathologic, lacking the ability to assemble
into the BLOC-3.
Results
Mutations of the HPS1 gene and phenotypes of the
Japanese patients To assess the occurrence of HPS1 in
the 24 patients who lacked mutations in the TYR (OCA2), P
(OCA2), TYRP1 (OCA3), or MATP (OCA4) gene among 93
unrelated Japanese OCA patients, we screened for muta-
tions in the HPS1 gene. As shown in Table I, among ten of
these patients we detected a total of eight different patho-
logic mutations (W583X, L668P, 288delT, 532insC, 974insC,
1323insA, 1691delA, and IVS5þ5G ! A), four of which
were novel (W583X, L668P, 532insC, and 1691delA). Anal-
ysis of DNA of 101 unrelated normally pigmented Japanese
individuals detected only one of these variants, IVS5þ
5G ! A, in a single heterozygous individual (Table II). This
IVS5þ5G ! A mutation, which we previously showed as
being pathologic with a sample of patient 5, causing aber-
rant pre-mRNA splicing with skipping of exon 5, and con-
sequent frameshift in the resulting HPS1 mRNA (Suzuki
et al, 2004), was observed in seven of the ten patients, three
of whom were homozygous for this mutation (Table I). Thus,
among these 93 Japanese patients thought to have OCA,
mutations in HPS1 occurred in 11% of the patients.
Clinical phenotypes of these ten patients with HPS1 are
summarized in Table I. All of the patients showed some
pigmentation, which, although variable, was generally more
than in patients with tyrosinase-negative OCA (OCA1A).
Prolonged bleeding time was confirmed in six of ten pa-
tients. The other four patients all had clinical evidence of a
bleeding diathesis, e.g. purpura on lower limbs or frequent
epistaxis, but their bleeding times were not tested. Pulmo-
nary fibrosis, confirmed by radiography and high-resolution
computerized tomography of the chest, was found only in
patient 4, who was 60 y old and had severe dyspnea. Pa-
tient 8, who was 39 y old, had no symptoms of pulmonary
fibrosis or colitis. The other eight patients were not exam-
ined for these complications, as they appeared too young to
exhibit symptoms.
Functional analysis of the L668P substitution by
complementation of HPS1-null mouse melanocytes The
L668P missense substitution involves an amino acid residue
conserved among most known species, including human,
mouse, rat, Xenopus, Fugu, and Ancylostoma, although
divergent in Drosophila (Y) and Mosquito (F). Furthermore,
the L668 substitution was not detected in any of the 101
Table I. Mutations and clinical phenotype of Japanese patients with HPS1
Patient Sex Age
Mutation Clinical phenotype
Maternal Paternal Hair color Iris color Nystagmus Bleeding time
1 F 3 mo IVS5þ 5G ! A 1691delA Brown Gray þ ND
2 F 10 mo W583X 974insC Light brown Brown þ 20 min
3 F 6 mo 974insC 288del T Blond Gray þ ND
4 M 60 y IVS5þ 5G ! A IVS5þ 5G ! A Blond Blue þ ND
5a M 2 y IVS5þ 5G ! A IVS5þ 5G ! A Blond Blue þ 10 min
6 M 1 mo 532insC 1323insA Blond Reddish brown þ 13 min
7 F 1 y L668P IVS5þ 5G ! A Yellow Blue þ 9.5 min
8 M 39 y (IVS5þ5G ! A)b (L668P)b Light brown Blue-brown þ ND
9 M 1.5 mo 974insC IVS5þ 5G ! A Blond Hazel þ 12 min
10 F 10 mo IVS5þ 5G ! A IVS5þ 5G ! A Blond Reddish brown  12 min
Novel mutations are in bold.
aA sample of patient 5 was used for the analysis for the IVS5þ5G ! A mutation causing aberrant pre-mRNA splicing (Suzuki et al, 2004).
bIt was not determined which mutations were of maternal or paternal origin in this patient. The normal value for the bleeding time is o6 min.
ND, not done; HPS, Hermansky–Pudlak syndrome.
Table II. Frequencies of mutations in Japanese patients with
HPS1 and normally pigmented Japanese subjects
Mutation
No. of alleles identiﬁed in
Japanese
patients with
HPS1 (n¼20)
Normally pigmented
Japanese subjects
(n¼ 202)
IVS5þ 5G ! A 10 (50%) 1 (0.5%)
c.974insC 3 (15%) 0
c.288delT 1 (5%) 0
c.1323insA 1 (5%) 0
p.W583X 1 (5%) 0
p.L668P 2 (10%) 0
c.532insC 1 (5%) 0
c.1691delA 1 (5%) 0
n, number of alleles examined; HPS1, Hermansky–Pudlak syndrome
type 1.
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Japanese control individuals tested. Together, these data
indicated that residue L668 was functionally important and
that L668P was not a common non-pathological poly-
morphism.
To assess the function of L668P-mutant HPS1 protein
experimentally, we tested the ability of the wild-type versus
mutant HPS1 polypeptides to constitute the BLOC-3 pro-
tein complex in mutant mouse melanocytes. We previously
showed that cultured melanocytes derived from ho-
mozygous Hps1-null (melan-ep) and Hps4-null (melan-le)
mutant mice both lacked the HPS1 protein, the apparent
result of protein destabilization by the absence of either one
of the complex components (Suzuki et al, 2002). To deter-
mine whether lack of the HPS1 protein likewise results in
destabilization of the HPS4 protein, we raised antisera to
the mouse HPS4 protein. As shown in Fig 1, western blot
analysis showed that both melan-ep and melan-le me-
lanocytes lack detectable  80 kDa HPS4 protein, indicat-
ing that the HPS4 protein was destabilized in Hps1-mutant
(melan-ep) melanocytes, just as the HPS1 protein was de-
stabilized in Hps4-mutant (melan-le) cells (Suzuki et al,
2002). These data thus demonstrated that lack of either the
HPS1 or HPS4 protein destabilized the other member of the
BLOC-3. Unexpectedly, we also found that the steady-state
quantity of HPS4 protein was reproducibly greater in Hps3-
mutant melan-coa melanocytes in wild-type (melan-a) cells
(Fig 1).
Chiang et al (2003) showed that overexpression of hu-
man HPS4 protein in melan-le melanocytes restores stabil-
ity of endogenous HPS1 protein, most likely by allowing
assembly of intact BLOC-3. We used an analogous ap-
proach to test whether the L668P mutant HPS1 protein
could stabilize endogenous HPS4 protein in transfected
melan-ep melanocytes. We transfected cells with cDNA
expression plasmids encoding either wild-type or L668P
mutant human HPS1 protein, and analyzed HPS1 and HPS4
protein expression by western blot assay. As shown in Fig 2,
overexpression of normal human HPS1 protein in trans-
fected melan-ep cells fully restored the stability of endog-
enous HPS4 protein (lane 1). Overexpression of L668P-
mutant HPS1 protein, however, failed to restore the stability
of endogenous HPS4 (lane 2). This result indicated that
L668P-mutant HPS1 was functionally incapable of assem-
bling with HPS4 in the BLOC-3 protein complex.
Haplotype analysis As discussed above, we found the
HPS1 IVS5þ5G ! A mutation in seven of the ten Japa-
nese HPS1 patients, three of whom were homozygous for
this mutation. This allele thus appears to be common
among Japanese HPS1 patients. To determine whether the
multiple occurrences of this allele might derive from a com-
mon founder, we carried out haplotype analysis of patients
and their parents for five single-nucleotide polymorphisms
(SNP) located within the HPS1 gene (Fig 3). As shown in
Table III, all alleles carrying the IVS5þ5G ! A mutation
appear to share the SNP haplotype C–C–G–G–A. In con-
trast, among 101 unrelated normally pigmented Japanese
controls, the C–C–G–G–A haplotype occurred with a fre-
quency of 6.3%. Thus, the relatively high frequency of the
HPS1 IVS5þ5G ! A mutation in Japanese patients ap-
pears to represent a founder effect for the mutation on this
island nation.
Mutational analysis of the HPS4 gene We additionally
screened for mutations in the HPS4 gene in the group of 14
Figure 1
Presence of Hermansky–Pudlak syndrome (HSP)4 protein in cul-
tured mouse melanocyte lines. Cell extracts of wild-type melan-a
(lane 1), Hps3-mutant (melan-coa; lane 2), Hps4-mutant (melan-le; lane
3), and Hps1—mutant (melan-ep; lane 4) melanocytes were immuno-
blotted using affinity-purified polyclonal antisera to mouse HPS4 pro-
tein. The mouse HPS4 protein reproducibly migrates at  80 kDa on
SDS-PAGE. Anti-b-actin antibody was used as a control for protein
loading.
Figure2
Expression of exogenous human Hermansky–Pudlak syndrome
type 1 (HPS1) and endogenous HPS4 proteins in melan-ep cells.
Melan-ep melanocytes were transfected using pIREShyg3-HPS1nor-
mal (lane 1), pIREShyg3-HPS1mutantL668P (lane 2), and by pIREShyg3
as a mock (lane 3). Then the cell extracts were immunoblotted using the
antibodies. Top: anti-HPS1 antibody; Middle: anti-HPS4 antibody; bot-
tom: anti-b-actin antibody as a control for protein loading. Exogenous
normal and L668P-mutant HPS1 protein were abundantly expressed in
transfected cells. Endogenous HPS4 protein, however, was restored
only in melan-ep cells transfected by the normal HPS1 expression
plasmid.
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OCA patients who remained undiagnosed. But we found no
pathological mutations of the HPS4 gene, indicating that
HPS4 may be rare among Japanese OCA patients.
Discussion
This is a molecular analysis that documents a significant
frequency of HPS among non-Puerto Rican patients with
OCA. Remarkably, as many as ten of 93 Japanese patients
with OCA were found to have HPS1, indicating that this
disorder, previously considered rare, is actually one of the
most common types of OCA among Japanese. Non-pig-
mentary features of HPS in these patients seem to be rel-
atively mild, and thus attracted little clinical attention,
resulting in these patients’ prior classification as having
non-syndromic ‘‘OCA’’. The diagnosis of HPS1 is very im-
portant, because it implies significant risk of major clinical
complications that do not occur in non-syndromic OCA,
including bleeding, pulmonary fibrosis, and colitis.
Only patient 4 developed pulmonary fibrosis. His
dyspnea was severe. No other patients had symptoms or
clinical evidence of either pulmonary fibrosis or colitis. Nev-
ertheless, it is inappropriate to conclude that there is a low
frequency of these complications among Japanese HPS1
patients, as eight of the ten patients studied here were
younger than 2 y of age. The age of onset of pulmonary
fibrosis in HPS is typically in the third or fourth decade
(Davies and Tuddenham, 1976), and the age of onset of
colitis in HPS is typically between 12 and 30 y (Schinella
et al, 1980). It will therefore be important to follow these
Japanese pediatric HPS1 patients carefully over several
decades to assess the occurrence of common HPS com-
plications.
In Puerto Rico, HPS is relatively frequent, a specific
HPS1 gene mutation having been amplified via the founder
effect because of occult inbreeding and genetic drift (Fukai
et al, 1995). An analogous situation pertains to the
IVS5þ 5G ! A mutation that we found in HPS patients
from Japan, where a founder effect appears to account for a
high frequency of this mutant allele among patients with
OCA. We also identified the 974insC mutation in three of ten
Japanese patients with HPS1. This mutation has been pre-
viously found in a number of European patients, with mul-
tiple independent mutational origins attributed to a
frameshift hotspot associated with a polycytosine tract
(Oh et al, 1998). Our findings extend this mutation to an
Asian population, most likely derived from at least one ad-
ditional independent origin at this mutational hotspot.
The L668P missense substitution described here is only
the second HPS1 missense substitution reported thus far,
and subjected to functional analysis. The HPS1 protein in-
teracts with the HPS4 protein in the BLOC-3 protein com-
plex, which is required for the biogenesis of various
lysosome-related organelles, including melanosomes. We
have shown that L668P-mutant HPS1 protein, whereas sta-
ble, lacks the ability to stabilize the HPS4 protein, suggest-
ing that L668P-HPS1 protein cannot assemble into BLOC-3.
Figure 3
Mutations of Hermansky–Pudlak syndrome type 1 (HPS1) gene.
Five single-nucleotide polymorphisms (SNP) used for the haplotype
analysis (upper) and eight mutations of HPS1 gene identified in this
study (lower). Asterisks indicate novel mutations identified in this study.
Table III. Identiﬁed haplotype with the IVS5þ 5G ! A mutation
Patient Mutation SNP1 SNP2 SNP3 SNP4 SNP5
1 IVS5þ5G ! A C C G G A
c.1691delA C A C C G
4 (Homozygote) IVS5þ5G ! A C C G G A
5 (Homozygote) IVS5þ5G ! A C C G G A
7 IVS5þ5G ! A C C G G A
p.L668P C C G C A
8 IVS5þ5G ! A C C G C/G A
p.L668P C C G C/G A
9 IVS5þ5G ! A C C G G A
c.974insC C A C C G
10 (homozygote) IVS5þ5G ! A C C G G A
Frequency (%) in normal Japanesea C: 91 C: 49 G: 57 G: 13 A: 57
aTwo hundred and two normally pigmented Japanese alleles were analyzed.
SNP, single-nucleotide polymorphism.
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This may implicate L668 in stabilization of or even binding to
HPS4. Interestingly, patients with the L668P mutation (pa-
tients 7 and 8 in Table I) manifested a relatively moderate
HPS1 clinical phenotype that included congenital nystag-
mus, OCA with some pigmentation, and mild bleeding ten-
dency (bleeding time; 9.5 min), suggesting that this variant
may not be functionally null in vivo.
Finally, we unexpectedly observed that the amount of
steady-state HPS4 protein is considerably greater in Hps3-
null (melan-coa) melanocytes than in wild-type mouse me-
lanocytes (see Fig 1). The HPS3 protein is a component of
the BLOC-2 (Gautam et al, 2004), whereas HPS4, like
HPS1, is a component of BLOC-3. These observations
suggest that there may be some functional relationship be-
tween BLOC-2 and BLOC-3, although its nature remains to
be elucidated.
Materials and Methods
Patients Twenty-four unrelated Japanese patients with OCA (six
females and 18 males) who had no mutations in the TYR, P, TYRP1,
and MATP genes were included in this study. Patients’ clinical
phenotypes are described in Table I. This study was approved by
the ethics committee of the Nagoya University School of Medicine.
Informed consent was obtained from each patient, or in the case of
children from the patient’s parents. The study was conducted ac-
cording to the Declaration of Helsinki Principles.
Mutation screening of the HPS1 gene DNA segments spanning
each of the 20 HPS1 genomic exons were amplified using primers
and PCR conditions described by Bailin et al (1997) and screened
for mutations by the simultaneous single-strand conformation po-
lymorphism (SSCP)/heteroduplex method (Lee et al, 1995). Two
kinds of SSCP gels, with glycerol concentrations of 7% and 10%,
were used to elevate the sensitivity of our mutation screening sys-
tem. PCR products showing aberrant patterns were reamplified
and sequenced directly using the genetic analysis system
CEQ2000XL (Beckman Coulter, Fullerton, California).
DNA constructs Full-length normal human HPS1 cDNA was
cloned in pCR2.1-TOPO (Invitrogen, Carlsbad, California), and
subsequently thymine at nucleotide position 2003 was substituted
by cytidine to create the L668P substitution by the site-directed
mutagenesis method (Giebel and Spritz, 1990). The cDNA were
then sequenced to confirm accuracy, and were inserted into mam-
malian expression plasmid pIREShyg3 (BD Biosciences, San Jose,
California), creating pIREShyg3-HPS1normal and pIREShyg3-
HPS1mutantL668P, respectively.
Cell cultures and cell transfection Melan-a, melan-coa, melan-
ep, and melan-le were cultured in RPMI-1640 medium with 10%
fetal calf serum, 200 nM 12-O-tetradecanoyl phorbol 13-acetate,
and 200 nM cholera toxin, in 10% CO2 as described (Suzuki
et al, 2001). Melan-ep mouse melanocytes were cultured for
24 h and transfected with 1.6 mg pIREShyg3, pIREShyg3-HPS1-
normal, or pIREShyg3-HPS1mutantL668P per 4 cm2 flask using
Lipofectamine 2000 reagent (Invitrogen). Stable tranformants were
selected in culture media containing 500 mg per mL hygromycin B
(Invitrogen).
Antibody production and immunoblotting Polyclonal antisera
against mouse HPS4 protein were raised by immunizing rabbits
with a synthesizetic peptide (486-DRTGFKPSPSGRH-498) as an-
tigen, and were then affinity purified using a smaller peptide (490-
FKPSPS-495) within the primary antigen peptide by Sigma Gen-
osis Japan (Hokkaido, Japan). Anti-HPS1 monoclonal antibody
(mAb hHPS5) was previously described (Oh et al, 2000). Anti-b-
actin monoclonal antibody was purchased from Sigma Genosis
Japan. HRP-conjugated secondary antibodies were from Da-
koCytomation (Glostrup, Denmark).
Cells were harvested by trypsin and centrifugation, washed
twice with cold PBS, and were resuspended in CF-PBS lysis buffer
(0.25 M sucrose, 25 mM KCl, 2.5mM MgCl2, 0.01% SDS). Cell
extracts from melanocytes were separated in 7.5% SuperSep po-
lyacrylamide gels (Wako, Osaka, Japan) and transferred to
Immobilon-P (Millipore, Billerica, Massachusetts). Membranes
were blocked in 5% fat-free milk in PBS plus 0.05% Tween-20
for 1 h at room temperature, and were then incubated in blocking
solution containing the appropriate primary antibody for 1 h at
room temperature. Membranes were then washed extensively, in-
cubated with appropriate HRP-conjugated secondary antibody for
1 h at room temperature, and washed again. Signals were detected
using ECL plus western blotting detection reagents (Amersham
Biosciences, Piscataway, New Jersey).
Haplotype analysis Figure 3 shows the positions of five SNP de-
rived from the genomic sequence of human chromosome 10 (Gen-
bank accession no. NT_030059): SNP1 (IVS1-9C ! T; SNP
accession no. rs2296429) is located in intron 1 of HPS1 gene,
SNP2 (nucleotide position 162C ! A; accession no. rs1804689) in
exon 2, SNP3 (IVS14þ 7G ! C; accession no. rs2296433) in intron
14, SNP4 (1472C ! G; accession no. rs2296434) in exon 15, and
SNP5 (IVS16-15A ! G; accession no. rs2296435) in intron 16.
SNP1 and SNP2 were detected with a primer set for exon 2. SNP3
was detected with a primer set for exon 14. SNP4 was detected
with a primer set for exon 15. SNP5 was detected with a primer set
for exon 17. SSCP analysis and direct sequencing were used for
genotyping. A haplotype of the allele with the mutation was con-
structed, based either on homozygosity or on the analyses of pa-
rental DNA. We also analyzed haplotypes of 101 unrelated normally
pigmented Japanese as controls by the PCR-SSCP/heteroduplex
method and direct sequencing, using the Estimating Haplotype-
frequencies (EH) software program (Terwlliger and Ott, 1994; Curtis
and Sham, 1995) to estimate the frequencies of five SNP in the
controls.
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